← All trials
NCT04553978
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 18, 2020
- Primary completion
- Mar 18, 2021
- Completion date
- Mar 18, 2021
- First posted
- Sep 18, 2020
- Last posted
- Sep 22, 2020
- Enrollment
- 8
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Hong Kong WD Pharmaceutical Co., LimitedLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.